VFA
IBB icon

Voya Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Voya Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,340
Closed -$1.08M – 402
2021
Q1 		$1.08M Buy
7,340
+1,040
+17% +$165K 0.04% 280
2020
Q4 		$961K Buy
6,300
+1,091
+21% +$156K 0.04% 280
2020
Q3 		$701K Buy
5,209
+1,147
+28% +$156K 0.03% 305
2020
Q2 		$547K Buy
4,062
+164
+4% +$20.9K 0.03% 341
2020
Q1 		$424K Sell
3,898
-3,980
-51% -$458K 0.02% 375
2019
Q4 		$947K Buy
7,878
+1,664
+27% +$186K 0.05% 280
2019
Q3 		$617K Sell
6,214
-1,078
-15% -$113K 0.03% 341
2019
Q2 		$782K Sell
7,292
-2
-0% -$213 0.04% 288
2019
Q1 		$798K Sell
7,294
-2,882
-28% -$316K 0.05% 265
2018
Q4 		$965K Sell
10,176
-160,566
-94% -$17M 0.06% 214
2018
Q3 		$20.8M Sell
170,742
-2,599
-1% -$306K 1.22% 16
2018
Q2 		$18.7M Buy
173,341
+185
+0.1% +$19.8K 1.22% 16
2018
Q1 		$18.4M Buy
173,156
+345
+0.2% +$38.2K 1.22% 15
2017
Q4 		$18.6M Sell
172,811
-2,155
-1% -$230K 1.2% 13
2017
Q3 		$19.3M Buy
174,966
+387
+0.2% +$41.4K 1.28% 16
2017
Q2 		$18.2M Sell
174,579
-2,298
-1% -$226K 1.29% 15
2017
Q1 		$17.4M Buy
176,877
+690
+0.4% +$66.1K 1.35% 16
2016
Q4 		$15.7M Sell
176,187
-5,241
-3% -$477K 1.37% 15
2016
Q3 		$17.3M Buy
181,428
+4,041
+2% +$384K 1.76% 11
2016
Q2 		$15.1M Sell
177,387
-759
-0.4% -$68.1K 1.77% 13
2016
Q1 		$15.1M Buy
178,146
+396
+0.2% +$35.4K 2.11% 8
2015
Q4 		$20.2M Buy
177,750
+5,001
+3% +$543K 2.99% 6
2015
Q3 		$16.7M Buy
172,749
+60,735
+54% +$7.28M 2.99% 7
2015
Q2 		$13.5M Buy
112,014
+5,067
+5% +$607K 2.38% 10
2015
Q1 		$12.5M Buy
+106,947
New +$11.8M 2.44% 5

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Voya Financial Advisors's IBB Position: Q2 2021 in Review

Voya Financial Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2021, closing a stake of 7,340 shares — an estimated $1.08M sold.

Voya Financial Advisors first reported a position in IBB in Q1 2015 and held it in 25 quarters. The position peaked at $20.8M in Q3 2018. 863 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

  • Voya Financial Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2021 after selling out during the quarter.
  • Voya Financial Advisors sold 7,340 iShares Biotechnology ETF shares in Q2 2021, an estimated $1.08M.
  • Voya Financial Advisors first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 25 quarters.
  • Voya Financial Advisors's iShares Biotechnology ETF position peaked at $20.8M in Q3 2018.
  • 863 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on Voya Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.